VANTABIO.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
VANTABIO.BOVanta Bioscience Limited	$20.58	+5.00%	$146M	—
ALFAVIO.BOAlfavision Overseas (India) Limited	$13.08	-2.39%	$412M	—
CHCL.BOCian Healthcare Limited	$5.01	+0.00%	$125M	—
CHEMOPH.BOChemo Pharma Laboratories Limited	$130.85	+0.00%	$196M	—
EMMESSA.BOEmmessar Biotech & Nutrition Limited	$24.60	+4.24%	$123M	—
GIANLIFE.BOGian Life Care Limited	$4.57	-3.59%	$47M	—
GVBL.BOGenomic Valley Biotech Ltd	$29.95	-0.50%	$91M	—

Source: Financial Modeling Prep · peers by sector/industry

Vanta Bioscience Limited

Vanta Bioscience Limited functions as an all-encompassing preclinical contract research organization (CRO). The firm extends a wide array of specialized offerings, including Discovery Toxicology, comprehensive assessments for Agro-Chemicals and overall Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Testing. This company commenced operations on April 29, 2016, and its main office is situated in Hyderabad, India.

www.vantabio.com

Employees: 48
IPO / List date: Oct 6, 2017
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds VANTABIO.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in VANTABIO.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded VANTABIO.BO yet.